Inventor · disambiguated record
Jonathan Zalevsky
Also filed as: ZALEVSKY JONATHAN
15 granted patents·16 pending applications·167 citations·filing 2002–2023
92Inventor score
Files withXENCOR INC21NEKTAR THERAPEUTICS7BIOXCEL THERAPEUTICS INC1BRISTOL MYERS SQUIBB CO1ZALEVSKY JONATHAN1
Top patents by PatentIndex Score
31 records- 0194US7662367B2Pharmaceutical compositions for the treatment of TNF-α related disordersXENCOR INC·Filed 2006·Granted Feb 16, 2010·30 cites·6 claims
- 0294US7446174B2Protein based TNF-α variants for the treatment of TNF-α related disordersXENCOR INC·Filed 2005·Granted Nov 4, 2008·27 cites·20 claims
- 0394US7244823B2TNF-alpha variants proteins for the treatment of TNF-alpha related disordersXENCOR INC·Filed 2002·Granted Jul 17, 2007·49 cites·36 claims
- 0492US7610156B2Methods for rational pegylation of proteinsXENCOR INC·Filed 2004·Granted Oct 27, 2009·29 cites·16 claims
- 0585US11744898B2Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methodsNEKTAR THERAPEUTICS·Filed 2018·Granted Sep 5, 2023·2 cites·8 claims
- 0685US7642340B2PEGylated TNF-α variant proteinsXENCOR INC·Filed 2005·Granted Jan 5, 2010·6 cites·5 claims
- 0784US7459527B2BMP-7 variants with improved propertiesXENCOR INC·Filed 2005·Granted Dec 2, 2008·6 cites·2 claims
- 0881US7587286B2Methods for rational pegylation of proteinsXENCOR INC·Filed 2004·Granted Sep 8, 2009·7 cites·14 claims
- 0980US7592423B2Globular adiponectin variantsXENCOR INC·Filed 2006·Granted Sep 22, 2009·4 cites·8 claims
- 1079US7678886B2Pharmaceutical compositions of adiponectin variants and methods of storageXENCOR INC·Filed 2006·Granted Mar 16, 2010·1 cites·8 claims
- 1178US7709607B2Adiponectin variantsXENCOR INC·Filed 2006·Granted May 4, 2010·1 cites·7 claims
- 1277US12214045B2Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methodsNEKTAR THERAPEUTICS·Filed 2023·Granted Feb 4, 2025·0 cites·24 claims
- 1375US7687461B2Treatment of TNF-α related disorders with TNF-α variant proteinsXENCOR INC·Filed 2004·Granted Mar 30, 2010·5 cites·11 claims
- 1466US2008113410A1Method for Rational Pegylation of ProteinsXENCOR INC·Filed 2007·Application pending·0 cites
- 1562US2006257360A1Protein based TNF-alpha variants for the treatment of TNF-alpha related disordersXENCOR INC·Filed 2006·Application pending·0 cites
- 1660US2025049934A1DOSING REGIMENS FOR SELECTIVE TREG STIMULATOR RUR20kD-IL-2 AND RELATED COMPOSITIONSNEKTAR THERAPEUTICS·Filed 2022·Application pending·0 cites
- 1758US2006235204A1BMP-2 variants with improved propertiesXENCOR INC·Filed 2006·Application pending·0 cites
- 1856US2008070837A1BMP-4 variants with improved propertiesXENCOR INC·Filed 2006·Application pending·0 cites
- 1955US2007207961A1TNF-alpha VARIANTS PROTEINS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERSXENCOR INC·Filed 2007·Application pending·0 cites
- 2055US2007172449A1TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERSXENCOR INC·Filed 2006·Application pending·0 cites
- 2154US2005221443A1Tumor necrosis factor super family agonistsXENCOR INC·Filed 2004·Application pending·0 cites
- 2253US7749956B2Method of treatment using adiponectin variantsXENCOR INC·Filed 2006·Granted Jul 6, 2010·0 cites·19 claims
- 2348US2020317784A1Methods and compositions for treating cancer by modifying multiple arms of the immune systemBIOXCEL THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2444US12030940B2Immunotherapeutic tumor treatment methodNEKTAR THERAPEUTICS·Filed 2018·Granted Jul 9, 2024·0 cites·28 claims
- 2543US2021154277A1Immunotherapeutic combination for treating cancerNEKTAR THERAPEUTICS·Filed 2018·Application pending·0 cites
- 2642US2007054359A1Rational Chemical Modification of Adiponectin VariantsZALEVSKY JONATHAN·Filed 2006·Application pending·0 cites
- 2742US2021205413A1SELECTIVE TREG STIMULATOR RUR20kD-IL-2 AND RELATED COMPOSITIONSNEKTAR THERAPEUTICS·Filed 2019·Application pending·0 cites
- 2842US2021292415A1Methods of treating a tumorBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 2941US2007015909A1Adiponectin variantsXENCOR INC·Filed 2006·Application pending·0 cites
- 3040US2019275133A1Immunotherapeutic tumor treatment methodNEKTAR THERAPEUTICS·Filed 2017·Application pending·0 cites
- 3134US2010222272A1Pharmaceutical Compositions for the Treatment of TNF-Alpha Related DisordersXENCOR INC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →